RBM8A and neoplasm: Further sub-group analysis of multiple clinic pathological features of 371 liver hepatocellular carcinoma (LIHC) samples in the TCGA consistently showed high transcription of RBM8A. The transcription level of RBM8A was significantly higher in HCC patients than healthy people in subgroup analyses based on gender, age, ethnicity, disease stages and tumor grade (Figure 2).